awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38079075-88476D08-FB62-4851-B518-660C9A9383D7
Q38079075-88476D08-FB62-4851-B518-660C9A9383D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38079075-88476D08-FB62-4851-B518-660C9A9383D7
Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults.
P2860
Q38079075-88476D08-FB62-4851-B518-660C9A9383D7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38079075-88476D08-FB62-4851-B518-660C9A9383D7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e77a716abb8bd70250c2c0ba9955a4301394d03
P2860
FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).